Prostate cancer is the most commonly diagnosed malignancy in males in the Western world.
This review focuses on advances in biomarker discovery for prostate cancer by microarray …

The marker currently used for prostate cancer (CaP) detection is an increase in serum
prostate-specific antigen (PSA). However, the PSA test which may give false positive or …

Background There is no cure for castration-recurrent prostate cancer (CRPC) and the
mechanisms underlying this stage of the disease are unknown. Methods We analyzed the …

Although the transient receptor potential melastatin 8 (TRPM8) cold receptor is highly
expressed in prostate cancer (PCa) and constitutes a promising diagnostic and prognostic …

Background The calcium-permeable cation channel TRPM8 (melastatin-related transient
receptor potential member 8) is over-expressed in several cancers. The present study aimed …

Purpose: Targeted therapeutics have significantly changed the outcome for patients
diagnosed with cancer. Still, effective therapeutic intervention does not exist for many …

CUB and SUSHI multiple domain protein 1 (CSMD1) is a candidate tumour suppressor gene
that maps to chromosome 8p23, a region deleted in many tumour types including 50% of …

Identification of sensitive and specific biomarkers for early detection and prognosis of
prostate cancer is essential for timely and appropriate treatment of the disease in individual …

This review gives an overview of morphological and functional characteristics in the human
prostate. It will focus on the current knowledge about transient receptor potential (TRP) …

PURPOSE: Accurate estimates of recurrence risk are needed for optimal treatment of
patients with clinically localized prostate cancer. We combined an established nomogram …